ZOE Zoetis Inc.

XETRA · DE · Technology · Drug Manufacturers - Specialty & Generic · zoetis.com

62.14EUR+0.52%Mkt Cap: 27.77B $P/E: 11.473d ago

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the ani…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$64.70BUSDP/E 25.1

TAK

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$38.70BUSDP/E 18.3

ZTS

Zoetis Inc. Class A Common Stock

$28.80BUSDP/E 11.4

UTHR

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB

$14.24BUSDP/E 109.4

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

HIK

Hikma Pharmaceuticals PLC

$4.19BUSDP/E 11.9

INDV

Indivior Pharmaceuticals, Inc. - Common Stock

$4.21BUSDP/E 12.8

Key Statistics

Company

Market Cap27.77B USD

Enterprise Value36.00B USD

Revenue (TTM)10.35B USD

Gross Profit7.39B USD

Net Income (TTM)2.91B USD

Revenue/Share22.14 EUR

Last Price62.14 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees14.5K

CountryDE

SectorTechnology

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)11.47

P/E (Forward)—

PEG6.47

EV/EBITDA8.15

EV/Revenue3.48

P/S2.68

P/B9.17

EPS (TTM)5.21

EPS (Forward)—

52W Range

61.161% of range128.16

52W High128.16 EUR

52W Low61.16 EUR

Profitability

Gross Margin71.84%

Oper. Margin40.72%

EBITDA Margin42.69%

Profit Margin28.23%

ROE80.25%

ROA17.28%

Growth

Revenue Growth-0.20%

Earnings Growth1.20%

Cash Flow & Leverage

Operating CF3.16B USD

CapEx (TTM)675.00M USD

FCF Margin21.18%

FCF Yield7.90%

Net Debt8.24B USD

Net Debt/EBITDA1.86

Balance Sheet

Debt/Equity2.77

Current Ratio3.08

Quick Ratio1.57

Book Value/Sh6.74 EUR

Cash/Share4.06 EUR

Dividends

Fwd Div Rate1.82 EUR

Trail. Div Rate2.06 EUR

Div. Yield2.95%

5Y Avg Yield0.89%

Payout Ratio33.88%

Ex-Div DateJul 20, 2026

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.413.22M

Float412.37M

Insiders0.16%

Institutions100.33%

Technical

SMA 5064.44 (-3.6%)

SMA 20083.86 (-25.9%)

Beta0.73

S&P 52W Chg14.58%

Avg Vol (30d)1.42K

Avg Vol (10d)1.10K

Technical Indicators

RSI (14)43.3

MACD-0.7767

MACD Signal-0.7733

MACD Hist.-0.0034

BB Upper64.46 EUR

BB Middle62.73 EUR

BB Lower60.99 EUR

BB Width5.53%

ATR (14)1.392 EUR

Vol Ratio (20d)1.68x